Methylene blue is an FDA approved treatment for methemoglobinemia, a rare blood disorder where hemoglobin cannot effectively release oxygen to body tissues, by acting as a reducing agent to convert methemoglobin back to hemoglobin
In the following narrative, we summarize the compounds that have become more popular in HCC therapy in the last few years, which are able to inhibit HCC cells in different pathways from ferroptosis, and may play a great role in the future of hepatocellular carcinoma therapy ( Table 1 )
Large-scale reviews estimate prevalence globally in varying populations between 3% and 76% depending on definitions and age groups
A 30-day Vitamin C challenge shows that real skincare results come from consistency
This prevents early fatigue during the drip
BPC-157, a stable pentadecapeptide, in the treatment of various experimental gastrointestinal lesions